CAR-T cell therapy has shown promising results in multiple clinical trials, though there are significant barriers to its widespread use.

Such barriers include complex logistics, concerns over toxicity, and financial burden.

Despite the barriers and challenges, the positive outcomes seen as a result of CAR-T therapy outweigh the barriers and justify its continued use and development.